NDAORALSOLUTION
Approved
Jan 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRIMSOL is an oral solution formulation of trimethoprim hydrochloride, a dihydrofolate reductase inhibitor used to treat bacterial urinary tract infections. It is a small-molecule antibiotic that works by inhibiting bacterial DNA synthesis. The oral solution formulation provides an alternative delivery route for patients requiring trimethoprim monotherapy.
LOE Approaching
With LOE approaching and limited commercial data, the brand team is likely small and focused on defending market position in a declining revenue environment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career roles on PRIMSOL are primarily defensive and commercial in nature, focused on maintaining market share and managing the transition through LOE. This is a consolidation-phase opportunity best suited to professionals with experience in portfolio rationalization, generics strategy, or mature product management.
Brand ManagerField Sales Representative
Worked on PRIMSOL at TerSera Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.